Outcomes in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) treated with the androgen receptor inhibitor enzalutamide: Results from the phase III AFFIRM trial Meeting Abstract


Authors: Sternberg, C. N.; De Bono, J. S.; Chi, K. N.; Fizazi, K.; Mulders, P.; Hirmand, M.; Forer, D.; Scher, H. I.
Abstract Title: Outcomes in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) treated with the androgen receptor inhibitor enzalutamide: Results from the phase III AFFIRM trial
Meeting Title: 2013 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 6 Suppl.
Meeting Dates: 2013 Feb 14-16
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-02-20
Language: English
ACCESSION: WOS:000333679600019
DOI: 10.1200/jco.2013.31.6_suppl.16
PROVIDER: wos
Notes: Meeting Abstract: 16 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Howard Scher
    1130 Scher